KATIE BURNS: Open Payments
NPI 1033821269 · CLARINDA, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 33 payments from 7 companies in 2025. Trend: 2023 $130 · 2024 $185 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $160 |
| Lilly USA, LLC | 11 | $135 |
| Viatris Specialty LLC | 3 | $46 |
| Novo Nordisk Inc | 2 | $35 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
| Mallinckrodt Hospital Products Inc. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: MOUNJARO, UBRELVY, QULIPTA, YUPELRI, Ozempic, Rybelsus, JOURNAVX, ACTHAR.
Industry payments across IA — which companies pay providers there.
